Skip to main content
Michael  Curtis

Dr Michael Curtis PhD DSP FHEA FBPhS

Reader in Pharmacology

Research interests

  • Pharmacology

Biography

I trained at the University of London (UK), and the University of British Columbia (Vancouver Canada). I have conducted research on cardiac arrhythmias and antiarrhythmic drugs for more than 30 years. I have served the British Pharmacological Society in a number of capacities, including senior editor of British Journal of Pharmacology (BJP), and champion of the journal’s design and analysis initiatives (see Br J Pharmacology 175 987-993, 2018). 

    Research

    King’s Open Research Group Initiative (KORGI)

    The King’s Open Research Group Initiative (or KORGI) is an action-oriented committee composed of an interdisciplinary mix of senior academics and experienced research staff that seek to change policy and procedures to promote transparent, accessible and reproducible research.

    AdobeStock_276394749
    Centre for Doctoral Training in Digital Twins for Healthcare

    DT4Health brings together a world-class multidisciplinary team of supervisors to train future innovation leaders to articulate and materialise the Digital Twin vision in healthcare.

    News

    Dr Louise Hesketh wins Cardiac Safety Early Career Seminar Award

    A postdoctoral researcher in the School of Cardiovascular and Metabolic Medicine & Sciences has been presented with the Cardiac Safety Early Career Seminar...

    Dr Louise Hesketh

    New drug that may prevent sudden cardiac death without any side-effects

    The new drug, named OCT2013, was found in animal experiments to prevent lethal arrhythmias and ventricular fibrillation as effectively as lidocaine but...

    new drug treating VF 780x440

    Assay validated for characterising a new drug for sudden cardiac death

    A team of researchers from the School of Cardiovascular & Medicine Sciences have developed a novel antiarrhythmic drug that appears to be devoid of the...

    Cardiovascular

    Features

    5 minutes with Michael Curtis

    Dr Michael Curtis is a Reader in Pharmacology within the School of Cardiovascular Medicine & Sciences.

    michael-curtis-5-min-with-hero-banner

      Research

      King’s Open Research Group Initiative (KORGI)

      The King’s Open Research Group Initiative (or KORGI) is an action-oriented committee composed of an interdisciplinary mix of senior academics and experienced research staff that seek to change policy and procedures to promote transparent, accessible and reproducible research.

      AdobeStock_276394749
      Centre for Doctoral Training in Digital Twins for Healthcare

      DT4Health brings together a world-class multidisciplinary team of supervisors to train future innovation leaders to articulate and materialise the Digital Twin vision in healthcare.

      News

      Dr Louise Hesketh wins Cardiac Safety Early Career Seminar Award

      A postdoctoral researcher in the School of Cardiovascular and Metabolic Medicine & Sciences has been presented with the Cardiac Safety Early Career Seminar...

      Dr Louise Hesketh

      New drug that may prevent sudden cardiac death without any side-effects

      The new drug, named OCT2013, was found in animal experiments to prevent lethal arrhythmias and ventricular fibrillation as effectively as lidocaine but...

      new drug treating VF 780x440

      Assay validated for characterising a new drug for sudden cardiac death

      A team of researchers from the School of Cardiovascular & Medicine Sciences have developed a novel antiarrhythmic drug that appears to be devoid of the...

      Cardiovascular

      Features

      5 minutes with Michael Curtis

      Dr Michael Curtis is a Reader in Pharmacology within the School of Cardiovascular Medicine & Sciences.

      michael-curtis-5-min-with-hero-banner